0001055726-21-000004.txt : 20210115
0001055726-21-000004.hdr.sgml : 20210115
20210115192541
ACCESSION NUMBER: 0001055726-21-000004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210115
FILED AS OF DATE: 20210115
DATE AS OF CHANGE: 20210115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KIES PETER
CENTRAL INDEX KEY: 0001259780
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14888
FILM NUMBER: 21533419
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INOVIO PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001055726
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330969592
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6769 MESA RIDGE RD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8584103134
MAIL ADDRESS:
STREET 1: 6769 MESA RIDGE RD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: INOVIO BIOMEDICAL CORP
DATE OF NAME CHANGE: 20050404
FORMER COMPANY:
FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL CORP
DATE OF NAME CHANGE: 20011116
FORMER COMPANY:
FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL LTD
DATE OF NAME CHANGE: 19980213
4
1
wf-form4_161075672601972.xml
FORM 4
X0306
4
2021-01-15
0
0001055726
INOVIO PHARMACEUTICALS, INC.
INO
0001259780
KIES PETER
C/O INOVIO PHARMACEUTICALS, INC.
6769 MESA RIDGE ROAD
SAN DIEGO
CA
92121
0
1
0
0
CFO
Common Stock
2021-01-15
4
M
0
30000
4.56
A
149290
D
Common Stock
2021-01-15
4
S
0
30000
10.0186
D
119290
D
Common Stock
4500
I
By Spouse
Common Stock Option
4.56
2021-01-15
4
M
0
30000
0
D
2011-03-11
2021-03-11
Common Stock
30000.0
0
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
These transactions were executed in multiple trades at prices ranging from $10.00 to $10.07, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014.
Peter Kies
2021-01-15